XML 43 R26.htm IDEA: XBRL DOCUMENT
v3.20.4

Acquisition (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Business Combinations [Abstract] |
Schedule of Consideration Paid for IPR&D | The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company’s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands):
Consideration |  |  |  |
Cash consideration |  | $ | 3,574 |
Stock consideration (3,067,179 shares at $3.01 per share) |  |  | 9,250 |
Transaction costs |  |  | 531 |
Repayment of debt |  |  | 11 |
Liabilities assumed |  |  | 22 |
Cash acquired |  |  | (155 | )
Total consideration paid for IPR&D |  | $ | 13,233 |

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration